US6465239B1
(en)
|
1993-03-19 |
2002-10-15 |
The John Hopkins University School Of Medicine |
Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species
|
US6607884B1
(en)
|
1993-03-19 |
2003-08-19 |
The Johns Hopkins University School Of Medicine |
Methods of detecting growth differentiation factor-8
|
ES2201076T3
(es)
|
1993-03-19 |
2004-03-16 |
The Johns Hopkins University School Of Medicine |
Factor-8 de diferenciacion del crecimiento.
|
US7393682B1
(en)
|
1993-03-19 |
2008-07-01 |
The Johns Hopkins University School Of Medicine |
Polynucleotides encoding promyostatin polypeptides
|
US7566768B1
(en)
|
1995-10-26 |
2009-07-28 |
The Johns Hopkins University School Of Medicine |
Promyostatin peptides and methods of using same
|
ATE258984T1
(de)
*
|
1993-05-12 |
2004-02-15 |
Inst Genetics Llc |
Bmp-11 zusammensetzungen
|
US7332575B2
(en)
|
1994-03-18 |
2008-02-19 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
|
US6008434A
(en)
|
1994-07-08 |
1999-12-28 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-11 transgenic mice
|
US20030167492A1
(en)
|
1994-07-08 |
2003-09-04 |
Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
|
US5846770A
(en)
*
|
1994-11-22 |
1998-12-08 |
Genetics Institute, Inc. |
DNA molecules encoding human chordin
|
US6524802B1
(en)
|
1996-03-29 |
2003-02-25 |
The Johns Hopkins University School Of Medicine |
Methods of detecting growth differentiation factor-14
|
US5965403A
(en)
|
1996-09-18 |
1999-10-12 |
Genetics Institute, Inc. |
Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
|
US7041641B2
(en)
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
WO1998054572A1
(en)
|
1997-05-30 |
1998-12-03 |
Creative Biomolecules, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
US6891082B2
(en)
*
|
1997-08-01 |
2005-05-10 |
The Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a truncated activintype II receptor
|
US6696260B1
(en)
*
|
1997-08-01 |
2004-02-24 |
The Johns Hopkins University School Of Medicine |
Methods to identify growth differentiation factor (GDF) binding proteins
|
US20020052026A1
(en)
|
1997-10-08 |
2002-05-02 |
Steven M. Vicik |
Methods of refolding proteins
|
WO1999024057A2
(en)
*
|
1997-11-07 |
1999-05-20 |
Genetics Inst |
Neuronal uses of bmp-11
|
US6027917A
(en)
*
|
1997-12-10 |
2000-02-22 |
Genetics Institute, Inc. |
Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
|
CA2319703C
(en)
*
|
1998-02-05 |
2005-09-20 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-8
|
US6369201B1
(en)
*
|
1998-02-19 |
2002-04-09 |
Metamorphix International, Inc. |
Myostatin multimers
|
US7147839B2
(en)
|
1998-05-29 |
2006-12-12 |
Curis, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
BR9912548A
(pt)
*
|
1998-07-28 |
2002-01-29 |
Univ Johns Hopkins Med |
Fator-11 de diferenciação de crescimento
|
WO2000043781A2
(en)
*
|
1999-01-21 |
2000-07-27 |
Metamorphix, Inc. |
Growth differentiation factor inhibitors and uses therefor
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
US6555374B1
(en)
*
|
1999-08-19 |
2003-04-29 |
Artecel Sciences, Inc. |
Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
|
TWI329129B
(en)
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
KR100420798B1
(ko)
*
|
2001-02-10 |
2004-03-02 |
(주)알에이싸이언스 |
펩타이드 벡터
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
US7320789B2
(en)
*
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
US6798160B2
(en)
*
|
2001-11-02 |
2004-09-28 |
Honda Giken Kogyo Kabushiki Kaisha |
Electric working machine
|
GB2385052A
(en)
|
2002-02-05 |
2003-08-13 |
Leuven K U Res & Dev |
Treatment of spondyloarthropathies
|
MXPA04008149A
(es)
*
|
2002-02-21 |
2005-06-17 |
Wyeth Corp |
Proteinas que contienen dominios de folistatina.
|
CA2476887A1
(en)
*
|
2002-02-21 |
2003-09-04 |
Wyeth |
Gasp1:a follistatin domain containing protein
|
US7527966B2
(en)
|
2002-06-26 |
2009-05-05 |
Transgenrx, Inc. |
Gene regulation in transgenic animals using a transposon-based vector
|
US20040172667A1
(en)
|
2002-06-26 |
2004-09-02 |
Cooper Richard K. |
Administration of transposon-based vectors to reproductive organs
|
BR0314270A
(pt)
*
|
2002-09-16 |
2005-08-02 |
Univ Johns Hopkins |
Ativação de miostatina com metaloprotease e processos de modulação da atividade da miostatina
|
AR047392A1
(es)
|
2002-10-22 |
2006-01-18 |
Wyeth Corp |
Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
UA85055C2
(ru)
*
|
2003-06-02 |
2008-12-25 |
Уайт |
Применение ингибиторов миостатика (gdf8) в сочетании с кортикостероидами для лечения нервно-мышечных заболеваний
|
CA2537735C
(en)
|
2003-09-12 |
2018-07-24 |
Wyeth |
Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
|
US8071364B2
(en)
|
2003-12-24 |
2011-12-06 |
Transgenrx, Inc. |
Gene therapy using transposon-based vectors
|
ATE478008T1
(de)
|
2004-03-10 |
2010-09-15 |
Scil Technology Gmbh |
Überzogene implantate, ihre herstellung und verwendung davon
|
EP1740609A2
(de)
|
2004-04-27 |
2007-01-10 |
Research Development Foundation |
Antagonismus des tgf-beta superfamily signal rezeptors
|
JP5201987B2
(ja)
|
2004-05-25 |
2013-06-05 |
ストライカー コーポレイション |
軟骨欠損を処置するための、形態形成タンパク質の使用
|
AU2005272646A1
(en)
*
|
2004-08-12 |
2006-02-23 |
Wyeth |
Combination therapy for diabetes, obesity, and cardiovascular diseases using GDF-8 inhibitors
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
AU2006226878A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Wyeth |
Detection of GDF-8 modulating agents
|
CA2601086A1
(en)
*
|
2005-03-23 |
2006-10-12 |
Wyeth |
Detection of an immune response to gdf-8 modulating agents
|
WO2007044411A2
(en)
*
|
2005-10-06 |
2007-04-19 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
UA92504C2
(en)
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
EP2311505B1
(de)
|
2006-02-09 |
2013-11-06 |
BioMimetic Therapeutics, LLC |
Zusammensetzungen und Verfahren zur Behandlung von Knochen
|
JP5219359B2
(ja)
|
2006-02-21 |
2013-06-26 |
日東電工株式会社 |
反射性及び/又は遮光性を有する粘着テープ又はシート、および液晶表示装置
|
US20090298761A1
(en)
|
2006-05-17 |
2009-12-03 |
Donald Engelman |
Methods of treating cartilage defects using a soluble morphogenic protein complex
|
EP2049145B1
(de)
|
2006-06-30 |
2018-03-14 |
BioMimetic Therapeutics, LLC |
Pdgf-biomatrix-zusammensetzungen und methode für die behandlung von rotationsmanschettenverletzungen
|
US9161967B2
(en)
|
2006-06-30 |
2015-10-20 |
Biomimetic Therapeutics, Llc |
Compositions and methods for treating the vertebral column
|
US8524265B2
(en)
|
2006-08-17 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Medical implant sheets useful for tissue regeneration
|
CN101511871B
(zh)
*
|
2006-09-05 |
2012-07-18 |
伊莱利利公司 |
抗肌肉生长抑制因子抗体
|
AU2007234612B2
(en)
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
US20100184659A1
(en)
|
2006-12-21 |
2010-07-22 |
Warren Jaworowicz |
Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
JP5323832B2
(ja)
|
2007-08-07 |
2013-10-23 |
アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー |
酸性水溶液中にgdf−5を含むタンパク質製剤
|
PE20091163A1
(es)
*
|
2007-11-01 |
2009-08-09 |
Wyeth Corp |
Anticuerpos para gdf8
|
CA2718592A1
(en)
|
2008-02-13 |
2009-08-20 |
Keith Hruska |
Method of treating vascular sclerosis
|
JP5599778B2
(ja)
|
2008-04-14 |
2014-10-01 |
デピュイ・シンセス・プロダクツ・エルエルシー |
液体緩衝gdf−5製剤
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
JP5816553B2
(ja)
|
2008-09-09 |
2015-11-18 |
バイオミメティック セラピューティクス, エルエルシー |
腱または靭帯の傷害を処置するための血小板由来成長因子組成物および方法
|
WO2010036976A2
(en)
|
2008-09-25 |
2010-04-01 |
Transgenrx, Inc. |
Novel vectors for production of antibodies
|
US9157097B2
(en)
|
2008-09-25 |
2015-10-13 |
Proteovec Holding, L.L.C. |
Vectors for production of growth hormone
|
US20100204123A1
(en)
|
2009-02-12 |
2010-08-12 |
Mary Elizabeth Pecquet Goad |
Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
|
JP5819734B2
(ja)
|
2009-02-12 |
2015-11-24 |
ストライカー コーポレイションStryker Corporation |
TGF−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法
|
WO2010110974A1
(en)
|
2009-03-24 |
2010-09-30 |
Stryker Corporation |
Methods and compositions for tissue engineering
|
US8609127B2
(en)
|
2009-04-03 |
2013-12-17 |
Warsaw Orthopedic, Inc. |
Medical implant with bioactive material and method of making the medical implant
|
EP2417263B1
(de)
|
2009-04-09 |
2015-09-23 |
ProteoVec Holding L.L.C. |
Herstellung von proteinen unter verwendung von vektoren auf transposonbasis
|
BRPI1010587A2
(pt)
*
|
2009-06-08 |
2019-04-09 |
Acceleron Pharma Inc. |
métodos para aumentar adipócitos termogênicos
|
US20110002897A1
(en)
|
2009-06-11 |
2011-01-06 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
KR20190090049A
(ko)
|
2009-06-12 |
2019-07-31 |
악셀레론 파마 인코포레이티드 |
절두된 ActRIIB-FC 융합 단백질
|
WO2011031856A1
(en)
|
2009-09-09 |
2011-03-17 |
Stryker Corporation |
Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint
|
EP2352750B1
(de)
|
2009-09-17 |
2012-06-13 |
Stryker Corporation |
Puffer zur steuerung des ph-wertes knochenmorphogenetischer proteine
|
WO2011087768A1
(en)
|
2009-12-22 |
2011-07-21 |
Stryker Corporation |
Bmp-7 variants with reduced immunogenicity
|
WO2011103598A1
(en)
|
2010-02-22 |
2011-08-25 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
|
WO2014012101A1
(en)
|
2012-07-13 |
2014-01-16 |
Trustees Of Tufts College |
Silk powder compaction for production of constructs with high mechanical strength and stiffness
|
NZ747350A
(en)
*
|
2012-10-24 |
2020-07-31 |
Celgene Corp |
Methods for treating anemia
|
IL267663B
(en)
*
|
2012-10-24 |
2022-09-01 |
Celgene Corp |
A biomarker for use in the treatment of anemia
|
BR112015009948B1
(pt)
|
2012-11-02 |
2022-12-06 |
Celgene Corporation |
Uso de um inibidor de actrii
|
WO2014127198A1
(en)
*
|
2013-02-15 |
2014-08-21 |
Joslin Diabetes Center |
Thymic regeneration
|
EP4140497A1
(de)
|
2013-04-08 |
2023-03-01 |
President and Fellows of Harvard College |
Zusammensetzungen zum verjüngen von stammzellen der skelettmuskulatur
|
WO2015070076A2
(en)
*
|
2013-11-08 |
2015-05-14 |
President And Fellows Of Harvard College |
Methods and compositions for rejuvenating neuromuscular junctions
|
JP2017530356A
(ja)
|
2014-09-26 |
2017-10-12 |
ソマロジック, インコーポレイテッドSomaLogic, Inc. |
心血管系のリスクイベントの予測及びその使用
|
EP3215175A4
(de)
|
2014-11-06 |
2018-06-27 |
Scholar Rock, Inc. |
Anti-pro/latentes-myostatin-antikörper und verwendungen davon
|
JP2018527903A
(ja)
*
|
2015-07-22 |
2018-09-27 |
スカラー ロック インコーポレイテッドScholar Rock,Inc. |
Gdf11結合タンパク質およびその使用
|
LT3350220T
(lt)
|
2015-09-15 |
2021-09-27 |
Scholar Rock, Inc. |
Anti pro/latentinio miostatino antikūnai ir jų panaudojimas
|
US10780171B2
(en)
|
2015-10-26 |
2020-09-22 |
President And Fellows Of Harvard College |
Reduced and oxidized polysaccharides and methods of use thereof
|
JP6948331B2
(ja)
|
2016-01-06 |
2021-10-13 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Gdf11での処置は、体重増加を防止し、耐糖能を改善し、そして脂肪肝を低減する
|
SG11201805709RA
(en)
|
2016-01-08 |
2018-07-30 |
Scholar Rock Inc |
Anti-pro/latent myostatin antibodies and methods of use thereof
|
EP4218804A3
(de)
|
2016-06-13 |
2023-09-13 |
Scholar Rock, Inc. |
Verwendung von myostatinhemmern und kombinationstherapien
|
SI3565592T1
(sl)
|
2017-01-06 |
2023-05-31 |
Scholar Rock, Inc. |
Zdravljenje presnovnih bolezni z zaviranjem aktivacije miostatina
|